Effect of Panax ginseng extract (G115) on angiotensin-converting enzyme (ACE) activity and nitric oxide (NO) production

Ackermann, 1998, Modulation of angiotensin-converting enzyme by nitric oxide, British Journal of Pharmacology, 124, 291, 10.1038/sj.bjp.0701836 Chen, 1996, Cardiovascular protection by ginsenosides and their nitric oxide releasing action, Clinical and Experimental Pharmacology and Physiology, 23, 728, 10.1111/j.1440-1681.1996.tb01767.x Chen, 1997, Extracts of Ginkgo biloba and ginsenosides exert cerebral vasorelaxation via a nitric oxide pathway, Clinical and Experimental Pharmacology and Physiology, 24, 958, 10.1111/j.1440-1681.1997.tb02727.x Chu, 1990, Anti-lipid peroxidation and protection of ginsenosides against cerebral ischemia-reperfusion injuries in rats, Zhongguo Yao Li Xue Bao, 11, 119 ESCOP Monograph, 2003. Ginseng Radix. In: ESCOP (Eds.), Georg Thieme Verlag, Stuttgart, pp. 211–222. Fernándes-Alfonso, 1999, Nitric oxide and the renin-angiotensin system. Is there a physiological interplay between the systems?, Journal of Hypertension, 17, 1355, 10.1097/00004872-199917100-00001 Friedl, 2001, Stimulation of nitric oxide synthesis by the aqueous extract of Panax ginseng root in RAW 264.7 cells, British Journal of Pharmacology, 134, 1663, 10.1038/sj.bjp.0704425 Han, 1996, Ginsenosides stimulate endogenous production of nitric oxide in rat kidney, International Journal of Biochemistry and Cell Biology, 28, 573, 10.1016/1357-2725(95)00163-8 Han, 1998, Effect of red ginseng on blood pressure in patients with essential hypertension and white coat hypertension, American Journal of Chinese Medicine, 26, 199, 10.1142/S0192415X98000257 Jacobsson, 1994, Anti-atherosclerotic effects of the angiotensin-converting enzyme inhibitors captopril and fosinopril in hypercholesterolemic mini pigs, Journal of Cardiovascular Pharmacology, 24, 670, 10.1097/00005344-199410000-00019 Jeon, 2000, Effect of Korea red ginseng on the blood pressure in conscious hypertensive rats, General Pharmacology, 35, 135, 10.1016/S0306-3623(01)00096-9 Kang, 1995, Ginsenosides of the protopanaxatriol group cause endothelium-dependent relaxation in the rat aorta, Life Sciences, 56, 1577, 10.1016/0024-3205(95)00124-O Keifer, 2003, Panax ginseng, American Family Physician, 68, 1539 Kim, 1992, Ginsenosides protect pulmonary vascular endothelium against free radical-induced injury, Biochemical and Biophysical Research Communication, 189, 670, 10.1016/0006-291X(92)92253-T Kim, 1994, Ginsenosides evoke endothelium-dependent vascular relaxation in rat aorta, General Pharmacology, 25, 1071, 10.1016/0306-3623(94)90121-X Kurz, 1999, Evidence for a casual role of the angiotensin-converting enzyme by nitric oxide, British Journal of Pharmacology, 124, 3181 Lauer, 2001, Plasma nitrite rather than nitrate reflects regional endothelial nitric oxide synthase activity but lacks intrinsic vasodilator action, Proceedings of the National Academy of Sciences of the U.S.A., 98, 12814, 10.1073/pnas.221381098 Li, 2001, Involvement of Ca2+-activated K+ channels in ginsenosides-induced aortic relaxation in rats, Journal of Cardiovascular Pharmacology, 37, 41, 10.1097/00005344-200101000-00005 Millatt, 1999, Angiotensin II and nitric oxide; a question of balance, Regulatory Peptides, 81, 1, 10.1016/S0167-0115(99)00027-0 Nyhlén, 2000, Corticosteroids and interferons inhibit cytokine induced production of IL-8 by human endothelial cells, Cytokine, 12, 355, 10.1006/cyto.1999.0557 Persson, 1998, Biphasic response to bradykinin in isolated porcine iliac arteries is mediated by bradykinin B1 and B2 receptors, Journal of Cardiovascular Pharmacology, 31, 306, 10.1097/00005344-199802000-00018 Persson, 1999, Nitric oxide modulates captopril-mediated angiotensin-converting enzyme inhibition in porcine iliac arteries, European Journal of Pharmacology, 385, 21, 10.1016/S0014-2999(99)00689-5 Persson, 2000, Nitric oxide donors and angiotensin-converting enzyme inhibitors act in concert to inhibit human angiotensin-converting enzyme activity and platelet aggregation in vitro, European Journal of Pharmacology, 406, 15, 10.1016/S0014-2999(00)00647-6 Rimar, 1996, Pulmonary protective vasodilator effects of a standardized Panax ginseng extract preparation following artificial gastric digestion, Pulmonary Pharmacology, 9, 205, 10.1006/pulp.1996.0025 Scott, 2001, Ginsenosides Rb1 and Re decrease cardiac contraction in adult rat ventricular myocytes: role of nitric oxide, British Journal of Pharmacology, 134, 1159, 10.1038/sj.bjp.0704377 Soldati, 2000, Panax ginseng: standardization and biological activity, 209 Sung, 2000, Effects of red ginseng upon vascular endothelial function in patients with essential hypertension, American Journal of Chinese Medicine, 28, 205, 10.1142/S0192415X00000258 WHO, 1999. Monograph radix ginseng. In: WHO Monographs on Selected Medicinal Plants, vol. 1, World Health Organization, Geneva, pp. 168–182. Yu, 2005, Lack of evidence for induction of CYP2B1, CYP3A23 and CYP1A2 gene expression by Panax ginseng and Panax quinquefolius extracts in adult rats and primary cultures of rat hepatocytes, Drug Metabolism and Disposition, 33, 19, 10.1124/dmd.104.001917 Zhu, 2004, Simultaneous determination of triterpene saponins in Ginseng drugs by high-performance liquid chromatography, Chemical Pharmaceutical Bulletin, 52, 995, 10.1248/cpb.52.995